ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
80,700
+100 (0.12%)
Jun 2, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Bio-Protein Recombinant Medicines
65.55B
Log In
Log In
Log In
Log In
Upgrade
Bio-Protein Recombinant Medicines Growth
-2.61%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
United States
63.55B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
1.98%
Log In
Log In
Log In
Log In
Upgrade
South Korea
2.00B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-16.30%
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade